What are the indications for rib plating?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Indications for Rib Plating (SSRF)

Rib plating should be performed for flail chest, multiple displaced rib fractures (≥3 ribs with ≥50% displacement), and patients with persistent respiratory impairment or severe pain despite optimal medical management. 1

Primary Indications

1. Flail Chest

  • Definitive indication: ≥2 consecutive ribs each fractured in ≥2 places creating paradoxical chest wall movement
  • Associated with reduced mortality, shorter mechanical ventilation, decreased pneumonia rates, and shorter ICU stays when surgically stabilized 1

2. Multiple Displaced Rib Fractures (Non-Flail)

Critical threshold: ≥3 ipsilateral displaced fractures of ribs 3-10 with displacement ≥50% of rib width on axial CT 1

Must have at least 2 of the following pulmonary derangements after initiation of regional anesthesia:

  • Respiratory rate >20 breaths/minute
  • Incentive spirometry <50% predicted
  • Pain score >5/10
  • Poor cough effectiveness

This represents the most recent high-quality evidence showing SSRF reduces pleural complications, pain, and respiratory disability 1

3. Unstable Chest Wall Injuries

Consider SSRF for:

  • ≥3 fractures with severe displacement (>100% overlap) or overriding (≥15mm each)
  • Rib protrusion into lung parenchyma
  • ≥25% hemithorax volume loss
  • Associated with decreased mortality (0% vs 6%) in ventilated patients 1

4. Persistent Severe Pain

  • Patients with severe pain despite multimodal analgesia and regional blocks
  • Pain as sole indication remains debated but shows reduced narcotic requirements post-operatively 2

Special Populations Where SSRF Should Be Considered

Traumatic Brain Injury (TBI)

  • Mild to moderate TBI (GCS 9-15): SSRF associated with lower pneumonia risk, reduced 30-day mortality, and shorter ICU stay 1
  • Severe TBI (GCS ≤8): Recent evidence shows reduced mortality with SSRF; no longer an absolute contraindication 1
  • Pneumonia is a strong independent predictor of mortality in polytrauma patients—SSRF helps prevent this 1

Elderly Patients

  • Do not withhold based on age alone 1
  • Elderly patients may benefit MORE than younger counterparts as they tolerate rib fractures poorly and deteriorate faster
  • SSRF safe and reduces mortality compared to non-operative management, though hospitalization may be longer 1

Pulmonary Contusion

  • Not a contraindication 1
  • Mild-moderate contusion: SSRF reduces respiratory failure, tracheostomy, mechanical ventilation duration, and hospital stay
  • Severe contusion: Recent evidence shows benefits regardless of severity 1

Timing Algorithm

Optimal window: 48-72 hours from injury 1

If contraindications exist initially (hemodynamic instability, ongoing resuscitation):

  • Perform SSRF as soon as stable, ideally within 3-7 days
  • Early SSRF minimizes pneumonia, reduces technical complexity (less inflammation, hematoma, callus formation)

Key Contraindications

Absolute

  • Hemodynamic instability (though patients on low, stable vasopressors may benefit if SSRF facilitates weaning sedation) 1
  • Age <18 years (FDA exclusion; plates may need removal within 3 months) 1

Relative (Assess individually)

  • Active empyema (hardware infection risk)
  • Prior chest wall radiation (hardware failure risk)
  • High spinal cord injury/quadriplegia (may not benefit from pain control)
  • Uncorrected coagulopathy
  • Terminal illness 1

Common Pitfalls to Avoid

  1. Waiting for "late failures": This introduces selection bias and misses the window for optimal benefit. Operate early (48-72h) when indicated 1

  2. Excluding elderly patients: Age alone should not preclude surgery—elderly patients often benefit most 1

  3. Assuming TBI is a contraindication: Even moderate-severe TBI patients benefit from SSRF with reduced mortality and pneumonia 1

  4. Dismissing non-ventilated patients: Those with ≥3 displaced fractures and persistent respiratory impairment/pain benefit significantly from SSRF 1

  5. Using pain as sole criterion without objective measures: Combine pain assessment with respiratory parameters (incentive spirometry, respiratory rate, cough effectiveness) 1

The evidence strongly supports expanding SSRF indications beyond traditional flail chest to include multiple displaced fractures with respiratory compromise, even in previously excluded populations like TBI and elderly patients 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.